Partnering

Partnering

Partners
for innovation
and success
Start »
Our approach

Complementing our own capabilities by establishing long-term relationships with innovative partners from science and industry is an essential element of our strategy. more
Our strengths

Bayer Schering Pharma is a strong player in specialty medicine. In the areas we focus on, we have a long-term tradition of belonging to the top players in the field. We do not only offer you in-depth knowledge of therapeutic approaches and specialized development expertise but also excellent sales and marketing capabilities worldwide. more
Selected partnerships

Bayer Schering Pharma has a long-term record of successful partnerships involving both large and small companies or academic institutions. Our activities span from inlicensing deals through co-marketing or co-promotion partnerships to collaborations where we outlicensed a substance. Here are some examples of our partnerships. more

News
Areas of interest
Partnering Meetings

News

06/17/2010
Bayer Schering Pharma and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
Collaboration Focuses on the Discovery and Development of Multiple Antibody, Protein and Small Molecule Agents Targeting the Wnt Pathway more

05/05/2010
Bayer Schering Pharma and EndoCeutics Enter into a Global Agreement for the Development and Commercialization of Vaginorm
Bayer Schering Pharma AG, Germany, announced that it has signed a global exclusive cooperation agreement with the Canadian company EndoCeutics, Inc. for the development and commercialization of Vaginorm, an intra-vaginal application of dehydroepiandrosterone (DHEA). A Phase III clinical program for Vaginorm in the treatment of symptoms of vulvovaginal atrophy and female sexual dysfunction in postmenopausal women has been initiated. more

Areas of interest

Here are our current search priorities per business unit and therapeutic area. We are looking for novel therapeutic approaches in the early research as well as in the development stage, and for marketed products which complement our product portfolio, both globally or regionally.
more

Partnering Meetings

The best way to discuss your ideas and opportunities for working together is to meet in person. Here you find a selection of the most important Partnering Meetings worldwide in 2010 where we are present. We are looking forward to meeting you there!
more

Innovation and success with excellent partners

We cooperate with external partners in science and industry
One important aspect of our strategy is cooperation with external partners in science and industry who have specialized knowledge and are willing to join us in taking on the challenges of developing and marketing new products.

We collaborate with our global network of partners in all phases of the value chain – from research and development to production and marketing. In this way, we can successfully and sustainably contribute to improving therapies together.